Top 50 Most Prescribed Medications

Why This Matters

As a nursing student in pharmacology, you're not just memorizing drug names. You're building a mental framework for understanding how medications work across body systems. The top prescribed medications represent the most common conditions you'll encounter: cardiovascular disease, metabolic disorders, mental health conditions, and chronic pain. Exam questions will test your ability to recognize drug classes, anticipate side effects, identify contraindications, and understand why one medication might be chosen over another for a specific patient.

These 50 medications demonstrate core pharmacological principles: receptor blocking, enzyme inhibition, hormone replacement, and neurotransmitter modulation. You'll see patterns emerge. ACE inhibitors and ARBs both target the renin-angiotensin system but through different mechanisms. SSRIs share a class but have different half-lives and interaction profiles. Don't just memorize individual drugs. Know what mechanism each one illustrates and how drugs within the same class compare.

---

Cardiovascular Agents: Blood Pressure & Heart Function

The cardiovascular medications you'll encounter most frequently work through distinct mechanisms: reducing cardiac workload, relaxing blood vessels, or blocking hormonal pathways that raise blood pressure. Understanding these mechanisms helps you anticipate side effects and recognize dangerous drug interactions.

Lisinopril

• ACE inhibitor that blocks conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone secretion
• Dry cough is the hallmark side effect, caused by bradykinin accumulation. If intolerable, the provider will typically switch to an ARB
• Hyperkalemia risk requires monitoring potassium levels, especially when combined with potassium-sparing diuretics or in patients with renal impairment
• Contraindicated in pregnancy (all trimesters) due to risk of fetal renal damage and other teratogenic effects

Losartan

• Angiotensin II receptor blocker (ARB) that blocks AT1 receptors directly. It achieves a similar endpoint as ACE inhibitors without affecting bradykinin
• No dry cough, making it the preferred alternative for patients who can't tolerate ACE inhibitors
• Renal protective effects in diabetic nephropathy make it first-line for hypertensive diabetics with proteinuria
• Also contraindicated in pregnancy, just like ACE inhibitors

Amlodipine

• Calcium channel blocker (dihydropyridine class) that relaxes vascular smooth muscle by blocking L-type calcium channels
• Peripheral edema is the most common side effect. This is caused by preferential arteriolar dilation, not fluid retention, so diuretics won't fix it
• Long half-life (30-50 hours) allows once-daily dosing and provides stable blood pressure control

Metoprolol

• Beta-1 selective blocker that reduces heart rate, contractility, and myocardial oxygen demand
• Fatigue and bradycardia are expected pharmacologic effects. Hold the dose and notify the provider if heart rate drops below 60 bpm (or per facility protocol)
• Do not stop abruptly. Taper gradually to avoid rebound tachycardia and hypertensive crisis
• Mask hypoglycemia symptoms in diabetic patients by blunting the tachycardic response to low blood sugar

Hydrochlorothiazide (HCTZ)

• Thiazide diuretic that inhibits the sodium-chloride cotransporter in the distal convoluted tubule
• Hypokalemia, hyponatremia, and hyperuricemia are key electrolyte disturbances to monitor. Hypokalemia is the most tested
• First-line for uncomplicated hypertension, often combined with ACE inhibitors or ARBs for synergistic effect
• Can worsen gout due to increased uric acid retention

Furosemide

• Loop diuretic that inhibits the sodium-potassium-chloride cotransporter in the ascending loop of Henle. This is the most potent diuretic class
• Rapid fluid removal makes it essential for acute pulmonary edema and heart failure exacerbations
• Ototoxicity risk increases with high IV doses or concurrent aminoglycoside use
• Monitor potassium closely. Hypokalemia from furosemide can be severe and rapid

---

Lipid-Lowering Agents: Statins & Cardiovascular Prevention

Statins remain the cornerstone of cardiovascular disease prevention. They work by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. This triggers the liver to upregulate LDL receptors, pulling more LDL out of the blood.

Atorvastatin

• High-intensity statin that can reduce LDL cholesterol by 50% or more at maximum doses
• Myopathy and rhabdomyolysis are serious risks. Instruct patients to report unexplained muscle pain, tenderness, or weakness immediately
• Hepatic metabolism via CYP3A4 creates interaction potential with grapefruit juice, macrolide antibiotics, and azole antifungals
• Can be taken at any time of day due to its long half-life (unlike simvastatin)

Simvastatin

• Moderate-intensity statin with a significant drug interaction profile due to CYP3A4 metabolism
• 80 mg dose restricted by FDA due to increased myopathy risk. Most patients are maintained at 40 mg or less
• Evening dosing recommended because cholesterol synthesis peaks overnight, and simvastatin's shorter half-life means timing matters

Aspirin (Low-Dose)

• Antiplatelet agent that irreversibly inhibits cyclooxygenase-1 (COX-1), preventing thromboxane A2 synthesis and platelet aggregation
• Low-dose (81 mg) for cardiovascular prevention in patients with established atherosclerotic disease. Higher doses provide anti-inflammatory effects but increase bleeding risk
• GI bleeding risk is the primary concern. Assess for concurrent NSAID use or anticoagulant therapy
• Irreversible effect means platelets are affected for their entire 7-10 day lifespan. This is why aspirin is held before surgery

---

Metabolic & Endocrine Agents: Diabetes & Thyroid

Metabolic medications require precise dosing and careful monitoring. These drugs replace deficient hormones or modify glucose metabolism, and therapeutic windows can be narrow.

Metformin

• Biguanide antidiabetic that decreases hepatic glucose production and improves peripheral insulin sensitivity. It does not cause hypoglycemia when used alone because it doesn't stimulate insulin release
• GI side effects (nausea, diarrhea) are common initially. Start low and titrate slowly. The extended-release formulation improves tolerability
• Hold before iodinated contrast procedures due to lactic acidosis risk, particularly in patients with renal impairment. Check renal function (eGFR) before restarting
• Can cause vitamin B12 deficiency with long-term use. Monitor levels periodically

Insulin Glargine

• Long-acting basal insulin with a relatively peakless 24-hour duration. It mimics physiologic basal insulin secretion
• Cannot be mixed with other insulins in the same syringe due to its acidic pH, which would alter absorption kinetics of both insulins
• Hypoglycemia risk requires thorough patient education on recognizing signs (shakiness, sweating, confusion) and treating with 15 g of fast-acting glucose (the "Rule of 15")
• Inject at the same time each day to maintain consistent basal coverage

Levothyroxine

• Synthetic T4 (thyroxine) that replaces deficient thyroid hormone in hypothyroidism
• Take on an empty stomach 30-60 minutes before breakfast. Calcium, iron, and antacids significantly reduce absorption, so separate these by at least 4 hours
• Narrow therapeutic index requires regular TSH monitoring (every 6-8 weeks after dose changes). Symptoms of over-replacement mimic hyperthyroidism: tachycardia, weight loss, anxiety, heat intolerance

---

Gastrointestinal Agents: Acid Suppression

Proton pump inhibitors dominate acid-related disorder treatment. They irreversibly inhibit the hydrogen-potassium ATPase pump in gastric parietal cells, providing more complete and longer-lasting acid suppression than H2 blockers like famotidine.

Omeprazole

• Proton pump inhibitor (PPI) that reduces gastric acid secretion by 90% or more when taken consistently
• Take 30-60 minutes before a meal for best effect. PPIs need active parietal cells (stimulated by eating) to work
• Long-term risks include vitamin B12 deficiency, hypomagnesemia, Clostridioides difficile infection, and increased fracture risk
• CYP2C19 inhibitor that can reduce clopidogrel activation. Consider pantoprazole as an alternative in cardiac patients on clopidogrel

Pantoprazole

• PPI with fewer drug interactions than omeprazole, making it preferred in patients on clopidogrel or multiple CYP-metabolized drugs
• IV formulation available for patients who cannot take oral medications or who have active upper GI bleeding
• Same long-term risks as other PPIs. Use the lowest effective dose for the shortest duration

---

Central Nervous System Agents: Mood & Anxiety

Antidepressants and anxiolytics work primarily by modulating neurotransmitter availability. SSRIs increase serotonin in the synaptic cleft by blocking its reuptake into the presynaptic neuron. Other agents have multimodal mechanisms. All antidepressants carry an FDA boxed warning for increased suicidal thinking in children, adolescents, and young adults (under 25), especially during the first few weeks of treatment.

Sertraline

• SSRI with a favorable side effect profile and broad FDA indications including depression, PTSD, OCD, and panic disorder
• Fewer CYP450 drug interactions than other SSRIs, making it relatively safe in patients on multiple medications
• Sexual dysfunction and GI upset are common side effects. Serotonin syndrome risk exists with MAOIs, tramadol, or other serotonergic agents. Symptoms include hyperthermia, clonus, agitation, and diaphoresis

Escitalopram

• S-enantiomer of citalopram, meaning it's the more pharmacologically active half of the parent compound
• QT prolongation risk is lower than citalopram but still requires caution with other QT-prolonging drugs (like certain antiarrhythmics or fluoroquinolones)
• Generally well-tolerated with predictable dosing. Often chosen as first-line for generalized anxiety disorder

Fluoxetine

• SSRI with the longest half-life (4-6 days for its active metabolite, norfluoxetine). This self-tapering property reduces the risk of discontinuation syndrome if doses are missed
• Strong CYP2D6 inhibitor, creating significant drug interaction potential with codeine (blocks conversion to morphine), tamoxifen (blocks conversion to active metabolite), and many antipsychotics
• Activating profile may worsen anxiety initially but can benefit patients with fatigue and low motivation

Trazodone

• Serotonin antagonist and reuptake inhibitor (SARI) with strong sedating properties at low doses
• Off-label insomnia use is far more common than its antidepressant indication. Typical sleep dose is 25-100 mg at bedtime; antidepressant doses are much higher (150-400 mg)
• Priapism is a rare but serious side effect requiring immediate medical attention. Counsel male patients to seek emergency care for prolonged erections

Gabapentin

• GABA analog that, despite its name, does not bind GABA receptors. It works by binding the alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release
• Neuropathic pain and seizure indications are FDA-approved. Also widely used off-label for anxiety, restless leg syndrome, and alcohol withdrawal
• Renal elimination requires dose adjustment in kidney disease. Sedation, dizziness, and peripheral edema are common side effects

---

Pain Management: Opioids, NSAIDs & Adjuvants

Pain medications range from mild anti-inflammatories to potent opioids. Understanding the WHO analgesic ladder and multimodal pain management is essential for safe administration. The goal is adequate pain control with the lowest effective dose and fewest side effects.

Hydrocodone/Acetaminophen

• Schedule II opioid combination providing moderate-to-severe pain relief through mu-opioid receptor agonism (hydrocodone) plus central analgesic effects (acetaminophen)
• Acetaminophen hepatotoxicity limits total daily acetaminophen to 3-4 g/day (varies by source and patient). Monitor for concurrent acetaminophen in OTC cold/flu products, which patients often don't realize contain it
• Respiratory depression, constipation, and dependence require careful patient selection and monitoring. Assess respiratory rate before each dose (hold if below 12 breaths/min, or per facility protocol)

Ibuprofen

• NSAID that inhibits both COX-1 and COX-2 enzymes, reducing prostaglandin synthesis and thereby decreasing inflammation, pain, and fever
• GI bleeding, renal impairment, and cardiovascular risk increase with prolonged use or high doses. Take with food to reduce GI irritation
• Avoid in third trimester of pregnancy due to risk of premature ductus arteriosus closure in the fetus

---

Respiratory Agents: Bronchodilators & Anti-Inflammatories

Respiratory medications target airway smooth muscle or inflammatory pathways. Quick-relief bronchodilators provide immediate symptom control, while controller medications prevent exacerbations over time.

Albuterol

• Short-acting beta-2 agonist (SABA) that relaxes bronchial smooth muscle within minutes
• Rescue inhaler for acute bronchospasm. If a patient is using their rescue inhaler more than twice a week (outside of exercise), that indicates poor asthma control and the need for controller therapy
• Tremor and tachycardia result from beta-receptor stimulation. Hypokalemia is possible with frequent use because beta-2 stimulation drives potassium into cells

Montelukast

• Leukotriene receptor antagonist that blocks inflammatory mediators involved in asthma and allergic rhinitis
• FDA boxed warning for neuropsychiatric effects including mood changes, agitation, and suicidal ideation. Monitor patients and counsel them to report behavioral changes
• Once-daily oral dosing improves adherence compared to inhaled controllers, though inhaled corticosteroids remain the preferred first-line controller for persistent asthma

---

Anti-Infectives: Antibiotics

Antibiotic stewardship requires understanding mechanisms, spectrums, and resistance patterns. Selecting the right antibiotic depends on the likely pathogen, site of infection, and patient-specific factors like allergies and renal function.

Amoxicillin

• Aminopenicillin with broad gram-positive and some gram-negative coverage. It inhibits bacterial cell wall synthesis by binding penicillin-binding proteins (PBPs)
• First-line for strep pharyngitis, acute otitis media, and some community-acquired pneumonia in appropriate patients
• Cross-reactivity with cephalosporins is lower than historically believed (approximately 1-2% in penicillin-allergic patients). True anaphylaxis to penicillin warrants more caution
• Rash with mononucleosis: patients with active EBV (mono) who take amoxicillin frequently develop a diffuse maculopapular rash. This is not a true allergy but is commonly tested

---

Quick Reference Table

---

Self-Check Questions

1. A patient on lisinopril develops a persistent dry cough. What medication class would you expect the provider to switch to, and why does this substitution resolve the cough?

2. Compare metformin and insulin glargine: Which can cause hypoglycemia when used as monotherapy, and what makes metformin the preferred first-line agent for type 2 diabetes?

3. A cardiac patient needs a PPI for GERD but is also taking clopidogrel. Which PPI would be preferred and why?

4. What distinguishes furosemide from hydrochlorothiazide in terms of potency and clinical indications? When would you use each?

5. A patient is prescribed both albuterol and montelukast for asthma. Explain the role of each medication and what it would indicate if the patient is using albuterol multiple times daily.

6. Why is fluoxetine less likely than other SSRIs to cause discontinuation syndrome? In what clinical situation could its long half-life be a disadvantage?

7. A patient on atorvastatin reports new-onset muscle pain. What is the concern, and what lab value might be ordered to evaluate it?